CLAYTON BRACKEEN: Open Payments
NPI 1891332292 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,534 in 79 payments from 14 companies in 2025. Trend: 2023 $2,094 · 2024 $1,374 · 2025 $1,534
Food & beverage: $1,468Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $261 |
| Arcutis Biotherapeutics, Inc. | 12 | $256 |
| Regeneron Healthcare Solutions, Inc. | 6 | $206 |
| ABBVIE INC. | 10 | $183 |
| UCB, Inc. | 8 | $161 |
| Organon LLC | 7 | $140 |
| Galderma Laboratories, L.P. | 4 | $64 |
| LEO Pharma Inc. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Lilly USA, LLC | 2 | $40 |
Products named: TREMFYA, Zoryve, DUPIXENT, Bimzelx, SKYRIZI, VTAMA, ADBRY, COSENTYX.
Industry payments across TX — which companies pay providers there.
